SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-009508
Filing Date
2023-05-12
Accepted
2023-05-12 08:02:13
Documents
15
Period of Report
2023-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ganx-20230512x8k.htm   iXBRL 8-K 29815
2 EX-99.1 ganx-20230512xex99d1.htm EX-99.1 171985
3 GRAPHIC ganx-20230512xex99d1002.jpg GRAPHIC 6595
  Complete submission text file 0001558370-23-009508.txt   356282

Data Files

Seq Description Document Type Size
4 EX-101.SCH ganx-20230512.xsd EX-101.SCH 3830
5 EX-101.DEF ganx-20230512_def.xml EX-101.DEF 2829
6 EX-101.LAB ganx-20230512_lab.xml EX-101.LAB 17910
7 EX-101.PRE ganx-20230512_pre.xml EX-101.PRE 10621
9 EXTRACTED XBRL INSTANCE DOCUMENT ganx-20230512x8k_htm.xml XML 5028
Mailing Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814
Business Address 4800 HAMPDEN LANE SUITE 200 BETHESDA MD 20814 (301) 500-1556
Gain Therapeutics, Inc. (Filer) CIK: 0001819411 (see all company filings)

IRS No.: 851726310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40237 | Film No.: 23913225
SIC: 2834 Pharmaceutical Preparations